Major Depressive Disorder Clinical Trials in Albuquerque, New Mexico

4 studies are recruiting for major depressive disorder in Albuquerque, New Mexico right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Enhancing Veteran-Clinical Collaboration in VA PRRCs

    Over 60% of Veterans with serious mental illness have a service-connected disability that impairs their ability to work, go to school, and/or have successful personal lives. Although traditional treatments tend to focus on symptom remission, Veterans prioritize a range of treatment goals, including…

    Stage
    Not phased
    Ages
    18 and older
    Site
    New Mexico VA Health Care System, Albuquerque, NM, Albuquerque, New Mexico
    Locations
    3 in total
    Run by
    VA Office of Research and Development

    See if you can join NCT06898879 on ClinicalTrials.gov

  2. A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

    X-NOVA2 is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of azetukalner as a monotherapy in adult participants diagnosed with Major Depressive Disorder (MDD)

    Stage
    Phase 3
    Ages
    18 to 74
    Site
    IMA Clinical Research, Albuquerque, New Mexico
    Locations
    51 in total
    Run by
    Xenon Pharmaceuticals Inc.

    See if you can join NCT06775379 on ClinicalTrials.gov

  3. A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

    The primary objective of this study is to evaluate the efficacy of NBI-1065845 compared with placebo as an adjunctive treatment in delaying relapse of depressive symptoms (maintenance of effect) in participants with MDD.

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Neurocrine Clinical Site, Albuquerque, New Mexico
    Locations
    60 in total
    Run by
    Neurocrine Biosciences

    See if you can join NCT07196501 on ClinicalTrials.gov

  4. Study of ALTO-300 in MDD

    The purpose of this study is to determine efficacy differences between ALTO-300 and placebo, used adjunctively to an antidepressant, related to patient characteristics.

    Stage
    Phase 2
    Ages
    18 to 70
    Site
    Site 114, Albuquerque, New Mexico
    Locations
    45 in total
    Run by
    Alto Neuroscience

    See if you can join NCT05922878 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.